Joseph Mellor
Overview
Explore the profile of Joseph Mellor including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
624
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mellor J, Kuznetsov D, Heller S, Gall M, Rosilio M, Amiel S, et al.
Diabetologia
. 2024 Jul;
67(10):2210-2224.
PMID: 39037602
Aims/hypothesis: Whether hypoglycaemia increases the risk of other adverse outcomes in diabetes remains controversial, especially for hypoglycaemia episodes not requiring assistance from another person. An objective of the Hypoglycaemia REdefining...
2.
McGurnaghan S, McKeigue P, Blackbourn L, Mellor J, Caparrotta T, Sattar N, et al.
Diabetes Care
. 2024 Jun;
47(8):1342-1349.
PMID: 38889071
Objective: In this study we examine whether hospitalized coronavirus disease 2019 (COVID-19) pneumonia increases long-term cardiovascular mortality more than other hospitalized pneumonias in people with type 2 diabetes and aim...
3.
Mellor J, Kuznetsov D, Heller S, Gall M, Rosilio M, Amiel S, et al.
Diabetologia
. 2024 May;
67(8):1588-1601.
PMID: 38795153
Aims/hypothesis: The objective of the Hypoglycaemia REdefining SOLutions for better liVES (Hypo-RESOLVE) project is to use a dataset of pooled clinical trials across pharmaceutical and device companies in people with...
4.
Berthon W, McGurnaghan S, Blackbourn L, Mellor J, Gibb F, Heller S, et al.
Diabetes Res Clin Pract
. 2024 Mar;
210:111642.
PMID: 38548109
Aims: We examined severe hospitalised hypoglycaemia (SHH) rates in people with type 1 and type 2 diabetes in Scotland during 2016-2022, stratifying by sociodemographics. Methods: Using the Scottish National diabetes...
5.
Mellor J, Jiang W, Fleming A, McGurnaghan S, Blackbourn L, Styles C, et al.
Br J Ophthalmol
. 2024 Feb;
108(6):833-839.
PMID: 38316534
Background/aims: National guidelines of many countries set screening intervals for diabetic retinopathy (DR) based on grading of the last screening retinal images. We explore the potential of deep learning (DL)...
6.
Fleming A, Mellor J, McGurnaghan S, Blackbourn L, Goatman K, Styles C, et al.
Br J Ophthalmol
. 2023 Sep;
108(7):984-988.
PMID: 37704266
Background/aims: Support vector machine-based automated grading (known as iGradingM) has been shown to be safe, cost-effective and robust in the diabetic retinopathy (DR) screening (DES) programme in Scotland. It triages...
7.
Mellor J, Jiang W, Fleming A, McGurnaghan S, Blackbourn L, Styles C, et al.
Int J Med Inform
. 2023 May;
175:105072.
PMID: 37167840
Aims: This study's objective was to evaluate whether deep learning (DL) on retinal photographs from a diabetic retinopathy screening programme improve prediction of incident cardiovascular disease (CVD). Methods: DL models...
8.
McGurnaghan S, Blackbourn L, Caparrotta T, Mellor J, Barnett A, Collier A, et al.
BMJ Open
. 2022 Oct;
12(10):e063046.
PMID: 36223968
Purpose: The Scottish Diabetes Research Network (SDRN)-diabetes research platform was established to combine disparate electronic health record data into research-ready linked datasets for diabetes research in Scotland. The resultant cohort,...
9.
Hohn A, McGurnaghan S, Caparrotta T, Jeyam A, OReilly J, Blackbourn L, et al.
PLoS One
. 2022 Aug;
17(8):e0271110.
PMID: 35951518
Background: We report the first study to estimate the socioeconomic gap in period life expectancy (LE) and life years spent with and without complications in a national cohort of individuals...
10.
OReilly J, Jeyam A, Caparrotta T, Mellor J, Hohn A, McKeigue P, et al.
Diabetes Care
. 2021 Jul;
44(9):2010-2017.
PMID: 34244330
Objective: Whether advances in the management of type 1 diabetes are reducing rates of diabetic ketoacidosis (DKA) is unclear. We investigated time trends in DKA rates in a national cohort...